Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.51%
#2 SAFEcoin SAFEcoin +29.03%
#3 Zora Zora +27.23%
#4 Pons Pons +27.21%
#5 0G 0G +25.84%
#6 QuantixAI QuantixAI +24.35%
#7 AI XOVIA AI XOVIA +18.73%
#8 Verus Coin Verus Coin +17.85%
#9 StonkBroker StonkBroker +17.56%
#10 ADO Protocol ADO Protocol +17.06%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Impact Therap-b Impact Therap-b

Impact Therap-b

7630
Rang în acțiuni #13199
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and... IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Preț acțiune
$1.85
Capitalizare de piață
$510.85M
Schimbare (1 zi)
-7.37%
Schimbare (1 an)
-
Țară
CN
Tranzacționează Impact Therap-b (7630)

Categorie

Healthcare
EPS pentru Impact Therap-b (7630)
EPS la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Impact Therap-b, EPS-ul actual al companiei (TTM) este 0. La sfârșitul anului 2026, compania avea un EPS de 0 egal cu EPS-ului din 2026, care a fost de 0.
Istoricul EPS pentru Impact Therap-b din 2026 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
Nu sunt suficiente date pentru perioada selectată.
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -
US